Telix Pharmaceuticals Ownership | Who Owns Telix Pharmaceuticals?


OverviewForecastChartTranscripts

Telix Pharmaceuticals Ownership Summary


Telix Pharmaceuticals is owned by 0.76% institutional investors, and 99.24% retail investors. Fmr is the largest institutional shareholder, holding 0.17% of TLX shares.

TLX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTelix Pharmaceuticals0.76%-99.24%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr564.76K0.17%$5.40M
Portolan capital management541.27K0.16%$5.18M
Lazard asset management289.92K0.09%$2.77M
Portland investment counsel266.20K0.08%$2.55M
Private advisor group174.41K0.05%$1.67M
Integrated wealth concepts164.40K0.05%$1.57M
Raiffeisen bank130.00K0.04%$1.16M
Morgan stanley116.44K0.03%$1.11M
Jpmorgan chase57.35K0.02%$513.84K
Mariner43.45K0.01%$415.34K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Portland investment counsel266.20K0.82%$2.55M
Portolan capital management541.27K0.28%$5.18M
Xy capital12.55K0.12%$120.12K
Raiffeisen bank130.00K0.02%$1.16M
Integrated wealth concepts164.40K0.01%$1.57M
Private advisor group174.41K0.01%$1.67M
Iht wealth management25.04K0.01%$239.59K
Lazard asset management289.92K0.00%$2.77M
Xtx topco26.01K0.00%$248.89K
Vanguard personalized indexing management33.25K0.00%$318.23K

Top Buyers

HolderShares% AssetsChange
Portolan capital management541.27K0.28%541.27K
Fmr564.76K0.00%441.19K
Integrated wealth concepts164.40K0.01%164.40K
Raiffeisen bank130.00K0.02%130.00K
Private advisor group174.41K0.01%128.07K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp---46.66K
Jane street group---40.04K
Quadrature capital---36.83K
Citadel advisors---23.00K
Millennium management---19.73K

New Positions

HolderShares% AssetsChangeValue
Portolan capital management541.27K0.28%541.27K$5.18M
Integrated wealth concepts164.40K0.01%164.40K$1.57M
Raiffeisen bank130.00K0.02%130.00K$1.16M
Schonfeld strategic advisors34.87K0.00%34.87K$333.73K
Xy capital12.55K0.12%12.55K$120.12K

Sold Out

HolderChange
True wealth design-3.00
Principal securities-21.00
Independence bank of kentucky-66.00
State of wyoming-1.29K
Hrt financial lp-11.64K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202636-7.69%2,556,082128.00%-684.36%25-7.41%9-
Dec 31, 202516-40.74%417,073-49.33%-207.58%12-42.86%2-50.00%
Sep 30, 20252728.57%823,17381.93%-1355.66%2110.53%4100.00%
Jun 30, 202521250.00%452,466849.62%-64776.39%19280.00%2100.00%
Mar 31, 20256500.00%47,6471177.40%-1161272.73%5400.00%1-

Insider Transactions Trends


DateBuySell
2026 Q1--
2010 Q4--
2007 Q4--
2007 Q3--
2006 Q1--

TLX Ownership FAQ


Who Owns Telix Pharmaceuticals?

Telix Pharmaceuticals shareholders are primarily institutional investors at 0.76%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Telix Pharmaceuticals's industry, Biotech Stocks , is 34.83%, which Telix Pharmaceuticals falls below.

Who owns the most shares of Telix Pharmaceuticals?

Telix Pharmaceuticals’s largest shareholders are Fmr (564.76K shares, 0.17%), Portolan capital management (541.27K shares, 0.16%), and Lazard asset management (289.92K shares, 0.09%). Together, they hold 0.41% of Telix Pharmaceuticals’s total shares outstanding.

Does Blackrock own Telix Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Telix Pharmaceuticals.

Who is Telix Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Portland investment counsel is Telix Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.82% of its assets in 266.2K Telix Pharmaceuticals shares, valued at 2.55M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools